PB Ratio
1.99
+0.04+2.05%
27 min ago
Summary:
Lineage Cell Therapeutics price to book ratio is currently 1.99, with a rise of +0.04 (+2.05%) during the most recent trading day. Over the past year, it has dropped by -0.58 (-22.57%). LCTX PB ratio is now -98.47% below its all-time high of 129.65.LCTX PB Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX PB Ratio Performance
| PeriodPeriod | PB ratioPB ratio | PricePrice | Market capMarket cap | PE ratioPE ratio |
|---|---|---|---|---|
| todaytoday | +2.0% | +1.9% | +1.9% | - |
| 1 m1 month | -19.8% | -33.8% | -20.0% | - |
| 3 m3 months | -22.0% | -37.5% | -24.4% | - |
| 6 m6 months | -18.8% | -38.8% | -26.1% | - |
| ytdytd | -33.9% | -47.2% | -31.1% | - |
| 1 y1 year | -22.6% | -42.4% | -24.9% | - |
| 5 y5 years | +73.0% | -36.0% | -2.5% | - |
LCTX PB Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 2.77 | -28.2% | 1.79 | +11.2% |
| 3 m | 3 months | 2.77 | -28.2% | 1.79 | +11.2% |
| 6 m | 6 months | 2.99 | -33.4% | 1.79 | +11.2% |
| 1 y | 1 year | 4.43 | -55.1% | 1.79 | +11.2% |
| 3 y | 3 years | 4.56 | -56.4% | 1.79 | +11.2% |
| 5 y | 5 years | 4.93 | -59.6% | 0.69 | +188.4% |
| alltime | all time | 129.65 | -98.5% | -551.45 | +100.4% |
Lineage Cell Therapeutics PB Ratio History
| Date | Value |
|---|---|
| 2024 | 1.99(-33.9%) |
| 2023 | 3.01(+11.1%) |
| 2022 | 2.71(-39.8%) |
| 2021 | 4.50(+60.7%) |
| 2020 | 2.80(+137.3%) |
| 2019 | 1.18(-4.1%) |
| 2018 | 1.23(-26.8%) |
| 2017 | 1.68(-46.7%) |
| 2016 | 3.15(-78.1%) |
| 2015 | 14.36(+62.3%) |
| 2014 | 8.85(-35.8%) |
| 2013 | 13.79(-14.8%) |
| 2012 | 16.18(+62.6%) |
| 2011 | 9.95(+1.8%) |
| 2010 | 9.77(-51.7%) |
| 2009 | 20.21(-308.6%) |
| Date | Value |
|---|---|
| 2008 | -9.69(+212.6%) |
| 2007 | -3.10(-5.2%) |
| 2006 | -3.27(-90.7%) |
| 2005 | -35.22(-145.2%) |
| 2004 | 78.00(-1106.5%) |
| 2003 | -7.75(-56.6%) |
| 2002 | -17.85(-96.7%) |
| 2001 | -539.71(-929.8%) |
| 2000 | 65.04(+242.0%) |
| 1999 | 19.02(-64.0%) |
| 1998 | 52.83(+61.0%) |
| 1997 | 32.82(-26.6%) |
| 1996 | 44.71(+3821.9%) |
| 1994 | 1.14(-77.2%) |
| 1993 | 4.99(+19.7%) |
| 1992 | 4.17 |
FAQ
- What is Lineage Cell Therapeutics price to book ratio?
- What is the all time high PB ratio for Lineage Cell Therapeutics?
- What is LCTX price to book ratio year-to-date change?
- What is Lineage Cell Therapeutics PB ratio year-on-year change?
What is Lineage Cell Therapeutics price to book ratio?
The current PB ratio of LCTX is 1.99
What is the all time high PB ratio for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high price to book ratio is 129.65
What is LCTX price to book ratio year-to-date change?
Lineage Cell Therapeutics price to book ratio has changed by -1.02 (-33.89%) since the beginning of the year
What is Lineage Cell Therapeutics PB ratio year-on-year change?
Over the past year, LCTX price to book ratio has changed by -0.58 (-22.57%)